6.82
price up icon18.82%   1.08
after-market Handel nachbörslich: 6.78 -0.04 -0.59%
loading

Finanzdaten der Jasper Therapeutics Inc-Aktie (JSPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
-0.118 0.051 -0.109 -0.07
Operating Expenses
14.97%
15.07
17.73 19.36 17.83 13.95
Depreciation and Amortization
0.288
- - 0.275 0.274
Operating Income/Loss
14.97%
-15.07
-17.73 -19.36 -17.83 -13.95
Nonoperating Income/Loss
1.344
- - - -
Income/Loss From Continuing Operations Before Tax
11,534%
-13.73
-0.118 0.051 -16.08 -14.26
Income/Loss From Continuing Operations After Tax
17.21%
-13.73
-16.58 -17.54 -16.08 -14.26
Net Income/Loss
17.21%
-13.73
-16.58 -17.54 16.10 -14.26
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
114.51%
13.33
-91.91 109.72 109.21 88.16
Diluted Average Shares
114.51%
13.33
-91.91 109.72 109.21 88.16
Basic Earnings Per Share
81.96%
-1.03
-5.71 -0.16 -0.15 -0.16
Diluted Earnings Per Share
81.96%
-1.03
-5.71 -0.16 -0.15 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):